{
  "paper_metadata": {
    "pmid": "31133063",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val28Ser",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val28Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Gly47Arg",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Thr49Ser",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Thr49Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Gly53Glu",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Thr60Ala",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Lys80Arg",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Gly83Arg",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P10",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Glu89Gln",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P11",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Ala97Gly",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P12",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Tyr114Ser",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P13",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Tyr114Cys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 42,
        "demographics": "Not specified",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 42,
        "affected_count": 38,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 90.48,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P14",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "We detected variant TTRs in 38 (91%) of 42 serum samples."
        }
      ],
      "functional_data": {
        "summary": "Direct MALDI method successfully detected variant TTRs.",
        "assays": [
          "MALDI-TOF MS"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Direct MALDI could not distinguish between Glu61Lys and Glu89Gln.",
      "key_quotes": [
        "We detected variant TTRs in 38 (91%) of 42 serum samples.",
        "Direct MALDI could not distinguish between two variant TTRs\u2014Glu61Lys and Glu89Gln."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Variant TTRs detected in 42 serum samples obtained from 42 patients with ATTRv amyloidosis by means of the direct MALDI method",
      "variants_extracted": 15
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 15,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All variants extracted were from the TTR gene."
  }
}